PRIZES to win! PROMOTIONS

Close Notification

Your cart does not contain any items

Californium-252 Isotope for 21st Century Radiotherapy

J.G. Wierzbicki

$126.95   $101.37

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Kluwer Academic Publishers
30 April 1997
Californium-252 is a neutron emitter with a high specific

activity, making it useful in a variety of applications, the most

spectacular of which is in brachytherapy for cancer patients.

Radiation oncology has exhausted nearly every option for treating

radioresistant tumors by photon brachytherapy, and therefore new types

of radiation need to be studied to improve the curability of cancer.

Audience: Californium brachytherapy is used in only a few

radiation therapy centers in the world, so the book will be highly

instructive for radiation oncologists, medical physicists and

radiobiologists. The nuclear techniques used in clinical applications

may also interest nuclear physicists and engineers.
Edited by:  
Imprint:   Kluwer Academic Publishers
Country of Publication:   United States
Edition:   1997 ed.
Volume:   29
Dimensions:   Height: 235mm,  Width: 155mm,  Spine: 230mm
Weight:   706g
ISBN:   9780792345435
ISBN 10:   0792345436
Series:   NATO Science Partnership Subseries: 3
Pages:   300
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
Yosh Maruyama — Father of Neutron Brachytherapy.- I. Production and Physical Properties of Californium Sources.- Californium-252 Production and Neutron Source Fabrication.- Physics and Dosimetry of Clinical 252Cf Sources.- II. Brachytherapy of Gynaecological Tumors.- Ta?ev of Cf-252 and Ra-226 Radiation Doses and the Reoxygenation and Regression of Cervix Uteri Tumor. Part I: Clinical Experimental Study.- The Relationship of Cf-252 and Ra-226 Radiation Doses and the Reoxygenation and Regression of Cervix Uteri Tumor. Part II: Preliminary Results in Advanced Cervical Carcinoma.- Californium-252 and Hypoxyradiotherapy in Treatment of Advanced Carcinoma of the Cervix Uteri.- Results of Mixed Radiation Therapy of Endometrial Cancer using Neutron Gamma-Therapy.- Preoperative Intracavitary Neutron Therapy Carcinoma of Endometrial and Cervix.- The Results of Treatment of Patients with Endometrial Cancer and Carcinoma Cervix using Californium-252 HDR.- Clinical Experience of Neutron Brachytherapy for Patients with Cervix Carcinoma.- III. Brachytherapy of Head and Neck Tumors.- Radiation Injuries of Oral Cavity and Oropharynx after Interstitial Neutron Brachytherapy and Gamma-Therapy.- Brachytherapy with Californium-252 for Head and Neck Tumors.- Immunoendocrine Homeostasis State in Patients with Cancer of the Buccal Mucosa after Interstitial Therapy with Californium-252.- IV. Brachytherapy of Rectal Tumors and Sarcomas.- Intracavitary Neutron Therapy for Malignant Rectal Tumors using High Cf-252 Sources.- Preoperative Radiotherapy in the Treatment of Rectal Carcinoma.- Californium-252 in the Treatment of Soft Tissue Sarcoma.- V. Dosimetry, Radiobiology and Treatment Planning of Mixed Neutron-Photon Radiation.- Treatment Planning for Interstitial and Intracavitary Cf-252Neutron Brachytherapy.- Dosimetry and Treatment Planning in High Dose Rate Cf-252 Brachytherapy.- To the Problem on Selection of the Target in Brachytherapy with Cf-252.- Factors Influencing the Efficiency of Cf-252 Brachytherapy: Clinical and Technological Aspects.- Biological Effects of Gamma-Neutron Radiation Cf-252 or Fission Neutron from the BR-10 Reactor on Tumor and Normal Cells and Tissues.- Cf-252 Brachytherapy in Cervical Cancer: Monte Carlo Studies of the Effect of Tissue Heterogeneity.- VI. Source Design and Delivery.- Automatic Afterloading Device for Neutron Brachytherapy (ANET-BA).- Small Accelerators — An Alternative Source of Neutrons for Brachytherapy.- The IEC as a Complementary Neutron Source to Cf-252.

See Also